Global Cell therapy Processing Market Size, Status and Forecast 2020-2026
- Report Code : SMA1862668
- Published On: Jul, 2020
- Category : Machinery & Equipment
- Pages : 132
-
This report focuses on the global Cell therapy Processing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cell therapy Processing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
Market segment by Type, the product can be split into
Products
Services
Software
Market segment by Application, split into
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cell therapy Processing status, future forecast, growth opportunity, key market and key players.
To present the Cell therapy Processing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Cell therapy Processing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
-
With tables and figures helping analyze worldwide Global Cell therapy Processing market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Report Overview1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cell therapy Processing Revenue
1.4 Market Analysis by Type
1.4.1 Global Cell therapy Processing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Products
1.4.3 Services
1.4.4 Software1.5 Market by Application
1.5.1 Global Cell therapy Processing Market Share by Application: 2020 VS 2026
1.5.2 Cardiovascular Disease
1.5.3 Bone Repair
1.5.4 Neurological Disorders
1.5.5 Skeletal Muscle RepairImmune Diseases1.6 Coronavirus Disease 2019 (Covid-19): Cell therapy Processing Industry Impact
1.6.1 How the Covid-19 is Affecting the Cell therapy Processing Industry
1.6.1.1 Cell therapy Processing Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Cell therapy Processing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Cell therapy Processing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions2.1 Cell therapy Processing Market Perspective (2015-2026)
2.2 Cell therapy Processing Growth Trends by Regions
2.2.1 Cell therapy Processing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cell therapy Processing Historic Market Share by Regions (2015-2020)
2.2.3 Cell therapy Processing Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cell therapy Processing Market Growth Strategy
2.3.6 Primary Interviews with Key Cell therapy Processing Players (Opinion Leaders)
3 Competition Landscape by Key Players3.1 Global Top Cell therapy Processing Players by Market Size
3.1.1 Global Top Cell therapy Processing Players by Revenue (2015-2020)
3.1.2 Global Cell therapy Processing Revenue Market Share by Players (2015-2020)
3.1.3 Global Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Cell therapy Processing Market Concentration Ratio
3.2.1 Global Cell therapy Processing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cell therapy Processing Revenue in 20193.3 Cell therapy Processing Key Players Head office and Area Served
3.4 Key Players Cell therapy Processing Product Solution and Service
3.5 Date of Enter into Cell therapy Processing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)4.1 Global Cell therapy Processing Historic Market Size by Type (2015-2020)
4.2 Global Cell therapy Processing Forecasted Market Size by Type (2021-2026)
5 Cell therapy Processing Breakdown Data by Application (2015-2026)5.1 Global Cell therapy Processing Market Size by Application (2015-2020)
5.2 Global Cell therapy Processing Forecasted Market Size by Application (2021-2026)
6 North America6.1 North America Cell therapy Processing Market Size (2015-2020)
6.2 Cell therapy Processing Key Players in North America (2019-2020)
6.3 North America Cell therapy Processing Market Size by Type (2015-2020)
6.4 North America Cell therapy Processing Market Size by Application (2015-2020)
7 Europe7.1 Europe Cell therapy Processing Market Size (2015-2020)
7.2 Cell therapy Processing Key Players in Europe (2019-2020)
7.3 Europe Cell therapy Processing Market Size by Type (2015-2020)
7.4 Europe Cell therapy Processing Market Size by Application (2015-2020)
8 China8.1 China Cell therapy Processing Market Size (2015-2020)
8.2 Cell therapy Processing Key Players in China (2019-2020)
8.3 China Cell therapy Processing Market Size by Type (2015-2020)
8.4 China Cell therapy Processing Market Size by Application (2015-2020)
9 Japan9.1 Japan Cell therapy Processing Market Size (2015-2020)
9.2 Cell therapy Processing Key Players in Japan (2019-2020)
9.3 Japan Cell therapy Processing Market Size by Type (2015-2020)
9.4 Japan Cell therapy Processing Market Size by Application (2015-2020)
10 Southeast Asia10.1 Southeast Asia Cell therapy Processing Market Size (2015-2020)
10.2 Cell therapy Processing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cell therapy Processing Market Size by Type (2015-2020)
10.4 Southeast Asia Cell therapy Processing Market Size by Application (2015-2020)
11 India11.1 India Cell therapy Processing Market Size (2015-2020)
11.2 Cell therapy Processing Key Players in India (2019-2020)
11.3 India Cell therapy Processing Market Size by Type (2015-2020)
11.4 India Cell therapy Processing Market Size by Application (2015-2020)
12 Central & South America12.1 Central & South America Cell therapy Processing Market Size (2015-2020)
12.2 Cell therapy Processing Key Players in Central & South America (2019-2020)
12.3 Central & South America Cell therapy Processing Market Size by Type (2015-2020)
12.4 Central & South America Cell therapy Processing Market Size by Application (2015-2020)
13 Key Players Profiles13.1 Anthrogenesis Corp.
13.1.1 Anthrogenesis Corp. Company Details
13.1.2 Anthrogenesis Corp. Business Overview and Its Total Revenue
13.1.3 Anthrogenesis Corp. Cell therapy Processing Introduction
13.1.4 Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2015-2020))
13.1.5 Anthrogenesis Corp. Recent Development13.2 BioNTech
13.2.1 BioNTech Company Details
13.2.2 BioNTech Business Overview and Its Total Revenue
13.2.3 BioNTech Cell therapy Processing Introduction
13.2.4 BioNTech Revenue in Cell therapy Processing Business (2015-2020)
13.2.5 BioNTech Recent Development13.3 Cell Ideas
13.3.1 Cell Ideas Company Details
13.3.2 Cell Ideas Business Overview and Its Total Revenue
13.3.3 Cell Ideas Cell therapy Processing Introduction
13.3.4 Cell Ideas Revenue in Cell therapy Processing Business (2015-2020)
13.3.5 Cell Ideas Recent Development13.4 Epic Sciences
13.4.1 Epic Sciences Company Details
13.4.2 Epic Sciences Business Overview and Its Total Revenue
13.4.3 Epic Sciences Cell therapy Processing Introduction
13.4.4 Epic Sciences Revenue in Cell therapy Processing Business (2015-2020)
13.4.5 Epic Sciences Recent Development13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview and Its Total Revenue
13.5.3 Roche Cell therapy Processing Introduction
13.5.4 Roche Revenue in Cell therapy Processing Business (2015-2020)
13.5.5 Roche Recent Development13.6 FuGENE
13.6.1 FuGENE Company Details
13.6.2 FuGENE Business Overview and Its Total Revenue
13.6.3 FuGENE Cell therapy Processing Introduction
13.6.4 FuGENE Revenue in Cell therapy Processing Business (2015-2020)
13.6.5 FuGENE Recent Development
13.7 IBC Pharmaceuticals Inc.
13.7.1 IBC Pharmaceuticals Inc. Company Details
13.7.2 IBC Pharmaceuticals Inc. Business Overview and Its Total Revenue
13.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Introduction
13.7.4 IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020)
13.7.5 IBC Pharmaceuticals Inc. Recent Development
13.8 Bluebird Bio Inc.
13.8.1 Bluebird Bio Inc. Company Details
13.8.2 Bluebird Bio Inc. Business Overview and Its Total Revenue
13.8.3 Bluebird Bio Inc. Cell therapy Processing Introduction
13.8.4 Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2015-2020)
13.8.5 Bluebird Bio Inc. Recent Development
13.9 Immodulon-Therapeutics
13.9.1 Immodulon-Therapeutics Company Details
13.9.2 Immodulon-Therapeutics Business Overview and Its Total Revenue
13.9.3 Immodulon-Therapeutics Cell therapy Processing Introduction
13.9.4 Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2015-2020)
13.9.5 Immodulon-Therapeutics Recent Development13.10 Immunomedics Inc.
13.10.1 Immunomedics Inc. Company Details
13.10.2 Immunomedics Inc. Business Overview and Its Total Revenue
13.10.3 Immunomedics Inc. Cell therapy Processing Introduction
13.10.4 Immunomedics Inc. Revenue in Cell therapy Processing Business (2015-2020)
13.10.5 Immunomedics Inc. Recent Development
13.11 Juno Therapeutics Inc.
10.11.1 Juno Therapeutics Inc. Company Details
10.11.2 Juno Therapeutics Inc. Business Overview and Its Total Revenue
10.11.3 Juno Therapeutics Inc. Cell therapy Processing Introduction
10.11.4 Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2015-2020)
10.11.5 Juno Therapeutics Inc. Recent Development
13.12 Medlmmune Inc.
10.12.1 Medlmmune Inc. Company Details
10.12.2 Medlmmune Inc. Business Overview and Its Total Revenue
10.12.3 Medlmmune Inc. Cell therapy Processing Introduction
10.12.4 Medlmmune Inc. Revenue in Cell therapy Processing Business (2015-2020)
10.12.5 Medlmmune Inc. Recent Development
13.13 NeoStem Oncology
10.13.1 NeoStem Oncology Company Details
10.13.2 NeoStem Oncology Business Overview and Its Total Revenue
10.13.3 NeoStem Oncology Cell therapy Processing Introduction
10.13.4 NeoStem Oncology Revenue in Cell therapy Processing Business (2015-2020)
10.13.5 NeoStem Oncology Recent Development
13.14 Neurotech USA
10.14.1 Neurotech USA Company Details
10.14.2 Neurotech USA Business Overview and Its Total Revenue
10.14.3 Neurotech USA Cell therapy Processing Introduction
10.14.4 Neurotech USA Revenue in Cell therapy Processing Business (2015-2020)
10.14.5 Neurotech USA Recent Development
13.15 Novartis
10.15.1 Novartis Company Details
10.15.2 Novartis Business Overview and Its Total Revenue
10.15.3 Novartis Cell therapy Processing Introduction
10.15.4 Novartis Revenue in Cell therapy Processing Business (2015-2020)
10.15.5 Novartis Recent Development
13.16 Persimmune Inc.
10.16.1 Persimmune Inc. Company Details
10.16.2 Persimmune Inc. Business Overview and Its Total Revenue
10.16.3 Persimmune Inc. Cell therapy Processing Introduction
10.16.4 Persimmune Inc. Revenue in Cell therapy Processing Business (2015-2020)
10.16.5 Persimmune Inc. Recent Development
13.17 Pluristem Therapeutics
10.17.1 Pluristem Therapeutics Company Details
10.17.2 Pluristem Therapeutics Business Overview and Its Total Revenue
10.17.3 Pluristem Therapeutics Cell therapy Processing Introduction
10.17.4 Pluristem Therapeutics Revenue in Cell therapy Processing Business (2015-2020)
10.17.5 Pluristem Therapeutics Recent Development
13.18 BioMed Valley Discoveries Inc.
10.18.1 BioMed Valley Discoveries Inc. Company Details
10.18.2 BioMed Valley Discoveries Inc. Business Overview and Its Total Revenue
10.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Introduction
10.18.4 BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2015-2020)
10.18.5 BioMed Valley Discoveries Inc. Recent Development
13.19 Regeneron Pharmaceuticals Inc.
10.19.1 Regeneron Pharmaceuticals Inc. Company Details
10.19.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
10.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Introduction
10.19.4 Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020)
10.19.5 Regeneron Pharmaceuticals Inc. Recent Development13.20 UCL Business PLC.
10.20.1 UCL Business PLC. Company Details
10.20.2 UCL Business PLC. Business Overview and Its Total Revenue
10.20.3 UCL Business PLC. Cell therapy Processing Introduction
10.20.4 UCL Business PLC. Revenue in Cell therapy Processing Business (2015-2020)
10.20.5 UCL Business PLC. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Cell therapy Processing Key Market Segments
Table 2. Key Players Covered: Ranking by Cell therapy Processing Revenue
Table 3. Ranking of Global Top Cell therapy Processing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cell therapy Processing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Products
Table 6. Key Players of Services
Table 7. Key Players of Software
Table 8. COVID-19 Impact Global Market: (Four Cell therapy Processing Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Cell therapy Processing Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Cell therapy Processing Players to Combat Covid-19 Impact
Table 13. Global Cell therapy Processing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Cell therapy Processing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Cell therapy Processing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Cell therapy Processing Market Share by Regions (2015-2020)
Table 17. Global Cell therapy Processing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Cell therapy Processing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Cell therapy Processing Market Growth Strategy
Table 23. Main Points Interviewed from Key Cell therapy Processing Players
Table 24. Global Cell therapy Processing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Cell therapy Processing Market Share by Players (2015-2020)
Table 26. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell therapy Processing as of 2019)
Table 27. Global Cell therapy Processing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Cell therapy Processing Product Solution and Service
Table 30. Date of Enter into Cell therapy Processing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Cell therapy Processing Market Size Share by Type (2015-2020)
Table 34. Global Cell therapy Processing Revenue Market Share by Type (2021-2026)
Table 35. Global Cell therapy Processing Market Size Share by Application (2015-2020)
Table 36. Global Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Cell therapy Processing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Cell therapy Processing Market Share (2019-2020)
Table 40. North America Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Cell therapy Processing Market Share by Type (2015-2020)
Table 42. North America Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Cell therapy Processing Market Share by Application (2015-2020)
Table 44. Europe Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Cell therapy Processing Market Share (2019-2020)
Table 46. Europe Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Cell therapy Processing Market Share by Type (2015-2020)
Table 48. Europe Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Cell therapy Processing Market Share by Application (2015-2020)
Table 50. China Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Cell therapy Processing Market Share (2019-2020)
Table 52. China Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 53. China Cell therapy Processing Market Share by Type (2015-2020)
Table 54. China Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 55. China Cell therapy Processing Market Share by Application (2015-2020)
Table 56. Japan Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Cell therapy Processing Market Share (2019-2020)
Table 58. Japan Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Cell therapy Processing Market Share by Type (2015-2020)
Table 60. Japan Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Cell therapy Processing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Cell therapy Processing Market Share (2019-2020)
Table 64. Southeast Asia Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Cell therapy Processing Market Share by Type (2015-2020)
Table 66. Southeast Asia Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Cell therapy Processing Market Share by Application (2015-2020)
Table 68. India Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Cell therapy Processing Market Share (2019-2020)
Table 70. India Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 71. India Cell therapy Processing Market Share by Type (2015-2020)
Table 72. India Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 73. India Cell therapy Processing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Cell therapy Processing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Cell therapy Processing Market Share (2019-2020)
Table 76. Central & South America Cell therapy Processing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Cell therapy Processing Market Share by Type (2015-2020)
Table 78. Central & South America Cell therapy Processing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Cell therapy Processing Market Share by Application (2015-2020)
Table 80. Anthrogenesis Corp. Company Details
Table 81. Anthrogenesis Corp. Business Overview
Table 82. Anthrogenesis Corp. Product
Table 83. Anthrogenesis Corp. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 84. Anthrogenesis Corp. Recent Development
Table 85. BioNTech Company Details
Table 86. BioNTech Business Overview
Table 87. BioNTech Product
Table 88. BioNTech Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 89. BioNTech Recent Development
Table 90. Cell Ideas Company Details
Table 91. Cell Ideas Business Overview
Table 92. Cell Ideas Product
Table 93. Cell Ideas Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 94. Cell Ideas Recent Development
Table 95. Epic Sciences Company Details
Table 96. Epic Sciences Business Overview
Table 97. Epic Sciences Product
Table 98. Epic Sciences Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 99. Epic Sciences Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. FuGENE Company Details
Table 106. FuGENE Business Overview
Table 107. FuGENE Product
Table 108. FuGENE Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 109. FuGENE Recent Development
Table 110. IBC Pharmaceuticals Inc. Company Details
Table 111. IBC Pharmaceuticals Inc. Business Overview
Table 112. IBC Pharmaceuticals Inc. Product
Table 113. IBC Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 114. IBC Pharmaceuticals Inc. Recent Development
Table 115. Bluebird Bio Inc. Business Overview
Table 116. Bluebird Bio Inc. Product
Table 117. Bluebird Bio Inc. Company Details
Table 118. Bluebird Bio Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 119. Bluebird Bio Inc. Recent Development
Table 120. Immodulon-Therapeutics Company Details
Table 121. Immodulon-Therapeutics Business Overview
Table 122. Immodulon-Therapeutics Product
Table 123. Immodulon-Therapeutics Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 124. Immodulon-Therapeutics Recent Development
Table 125. Immunomedics Inc. Company Details
Table 126. Immunomedics Inc. Business Overview
Table 127. Immunomedics Inc. Product
Table 128. Immunomedics Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 129. Immunomedics Inc. Recent Development
Table 130. Juno Therapeutics Inc. Company Details
Table 131. Juno Therapeutics Inc. Business Overview
Table 132. Juno Therapeutics Inc. Product
Table 133. Juno Therapeutics Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 134. Juno Therapeutics Inc. Recent Development
Table 135. Medlmmune Inc. Company Details
Table 136. Medlmmune Inc. Business Overview
Table 137. Medlmmune Inc. Product
Table 138. Medlmmune Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 139. Medlmmune Inc. Recent Development
Table 140. NeoStem Oncology Company Details
Table 141. NeoStem Oncology Business Overview
Table 142. NeoStem Oncology Product
Table 143. NeoStem Oncology Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 144. NeoStem Oncology Recent Development
Table 145. Neurotech USA Company Details
Table 146. Neurotech USA Business Overview
Table 147. Neurotech USA Product
Table 148. Neurotech USA Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 149. Neurotech USA Recent Development
Table 150. Novartis Company Details
Table 151. Novartis Business Overview
Table 152. Novartis Product
Table 153. Novartis Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 154. Novartis Recent Development
Table 155. Persimmune Inc. Company Details
Table 156. Persimmune Inc. Business Overview
Table 157. Persimmune Inc. Product
Table 158. Persimmune Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 159. Persimmune Inc. Recent Development
Table 160. Pluristem Therapeutics Company Details
Table 161. Pluristem Therapeutics Business Overview
Table 162. Pluristem Therapeutics Product
Table 163. Pluristem Therapeutics Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 164. Pluristem Therapeutics Recent Development
Table 165. BioMed Valley Discoveries Inc. Company Details
Table 166. BioMed Valley Discoveries Inc. Business Overview
Table 167. BioMed Valley Discoveries Inc. Product
Table 168. BioMed Valley Discoveries Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 169. BioMed Valley Discoveries Inc. Recent Development
Table 170. Regeneron Pharmaceuticals Inc. Company Details
Table 171. Regeneron Pharmaceuticals Inc. Business Overview
Table 172. Regeneron Pharmaceuticals Inc. Product
Table 173. Regeneron Pharmaceuticals Inc. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 174. Regeneron Pharmaceuticals Inc. Recent Development
Table 175. UCL Business PLC. Company Details
Table 176. UCL Business PLC. Business Overview
Table 177. UCL Business PLC. Product
Table 178. UCL Business PLC. Revenue in Cell therapy Processing Business (2015-2020) (Million US$)
Table 179. UCL Business PLC. Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell therapy Processing Market Share by Type: 2020 VS 2026
Figure 2. Products Features
Figure 3. Services Features
Figure 4. Software Features
Figure 5. Global Cell therapy Processing Market Share by Application: 2020 VS 2026
Figure 6. Cardiovascular Disease Case Studies
Figure 7. Bone Repair Case Studies
Figure 8. Neurological Disorders Case Studies
Figure 9. Skeletal Muscle RepairImmune Diseases Case Studies
Figure 10. Cell therapy Processing Report Years Considered
Figure 11. Global Cell therapy Processing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cell therapy Processing Market Share by Regions: 2020 VS 2026
Figure 13. Global Cell therapy Processing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cell therapy Processing Market Share by Players in 2019
Figure 16. Global Top Cell therapy Processing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell therapy Processing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cell therapy Processing Revenue in 2019
Figure 18. North America Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cell therapy Processing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Anthrogenesis Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Anthrogenesis Corp. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 27. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. BioNTech Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 29. Cell Ideas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Cell Ideas Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 31. Epic Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Epic Sciences Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 33. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Roche Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 35. FuGENE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. FuGENE Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 37. IBC Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. IBC Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 39. Bluebird Bio Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Bluebird Bio Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 41. Immodulon-Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Immodulon-Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 43. Immunomedics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Immunomedics Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 45. Juno Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Juno Therapeutics Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 47. Medlmmune Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Medlmmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 49. NeoStem Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. NeoStem Oncology Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 51. Neurotech USA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Neurotech USA Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 55. Persimmune Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Persimmune Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 57. Pluristem Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pluristem Therapeutics Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 59. BioMed Valley Discoveries Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. BioMed Valley Discoveries Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 61. Regeneron Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 63. UCL Business PLC. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. UCL Business PLC. Revenue Growth Rate in Cell therapy Processing Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
-
The Global Cell therapy Processing Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
Global Cell therapy Processing has a wide range of applications, including
According to the report, the Global Cell therapy Processing Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Cell therapy Processing Market as well as its distribution among its players
During the forecast years, the Global Cell therapy Processing Market can thrive with a robust CAGR.
